TATANISHA FUNCHES: Open Payments
NPI 1336667070 · WAUKEGAN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,876 in 38 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $340 · 2025 $1,876
Food & beverage: $1,876
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $525 |
| Teva Pharmaceuticals USA, Inc. | 5 | $309 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $279 |
| Novo Nordisk Inc | 4 | $244 |
| Otsuka America Pharmaceutical, Inc. | 2 | $233 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $177 |
| Lundbeck LLC | 6 | $110 |
Products named: REXULTI, AIRSUPRA, JARDIANCE, UZEDY, Ozempic, BREZTRI, CAPLYTA, FARXIGA.
Industry payments across IL — which companies pay providers there.
